UNSPSC 51313101: Cetirizine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C21H25ClN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YO7261ME24, chemically known as acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)- but generally known as cetirizine, which bears US NIH Compound Identifier 2678. European Medicines Agency schedules Cetirizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07451MIG.

UNSPSC 51313101 Cetirizine, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and drug deactivation systems, not cetirizine (an antihistamine allergy medication). This mismatch suggests either a coding error in the opportunity posting or that the code does not accurately reflect current state and local purchasing patterns for cetirizine itself. The opportunity that was posted does not represent genuine demand for the pharmaceutical product named in the code.

Seminole County issued the sole recent posting on June 30, 2026, as an Invitation for Bid with a response deadline of July 26, 2023 (note: the date appears inconsistent with the posting date). The solicitation called for 1,900 units of naloxone and 800 safe drug deactivation systems annually on a fixed-fee basis with a two-year initial term and one-year renewal option, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract was potentially FEMA-funded and required E-Verify compliance, workers' compensation insurance, and drug-free workplace certification. Given the absence of other recent opportunities under this code and the clear scope mismatch in the single posting, pursuit activity should be limited unless additional opportunities clarifying actual cetirizine procurement emerge.